# Clinical trials recruiting in Slovakia: 212 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 212 trials recruiting or not yet recruiting with a site in Slovakia, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Slovakia: 212 rows for $10.60, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/slovakia

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 212
- Recruiting or not yet: 212
- Read on: November 19, 2026

## Trials

The 25 newest of 212, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 12, 2026 | NCT07931495 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931495) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| October 22, 2026 | NCT07889089 | Effects of Sprint and Eccentric Hamstring Training in Elite Youth Soccer Players | Comenius University | Not applicable | Not yet recruiting | Sprint Mechanical Output, Sprint Performance, Eccentric Hamstring Strength | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07889089) |
| October 1, 2026 | NCT07851025 | Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced... | AstraZeneca | Phase 3 | Recruiting | Epithelial Ovarian Cancer | 950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851025) |
| September 29, 2026 | NCT07845487 | A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis | Sponsor not shown (see the record) | Phase 2 | Recruiting | Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis | 204 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845487) |
| September 8, 2026 | NCT07806266 | EORTC Metastatic Breast Cancer Module Development | University of Leeds | Observational | Recruiting | Metastatic Beast Cancer | 568 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07806266) |
| August 26, 2026 | NCT07786506 | Intermittent Theta-Burst Stimulation for Lower-Limb Spasticity and Pain in Multiple Sclerosis | Comenius University | Not applicable | Not yet recruiting | Multiple Sclerosis, Muscle Spasticity, Neuropathic Pain | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07786506) |
| August 25, 2026 | NCT07784270 | A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight | AstraZeneca | Phase 3 | Recruiting | Obesity or Overweight, Diabetes Mellitus, Type 2 | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07784270) |
| August 19, 2026 | NCT07772518 | Intracardiac Echocardiography-guided Versus Electroanatomical Mapping-guided Pulsed Field Ablation for Paroxysmal Atrial Fibrillation | Mitera Hospital | Not applicable | Recruiting | Paroxysmal Atrial Fibrillation (PAF) | 292 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07772518) |
| August 12, 2026 | NCT07761117 | A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF | AstraZeneca | Phase 3 | Recruiting | Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) | 6,950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07761117) |
| August 6, 2026 | NCT07749183 | A Photoplethysmography-Based Machine Learning Algorithm for Early Atrial Fibrillation Detection: A Prospective Validation Study | Sponsor not shown (see the record) | Observational | Recruiting | Atrial Fibrillation (AF), Heart Failure | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07749183) |
| July 9, 2026 | NCT07691970 | Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From... | AstraZeneca | Phase 3 | Recruiting | Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus | 1,072 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07691970) |
| July 6, 2026 | NCT07682818 | Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function | Zealand Pharma | Phase 1 | Recruiting | Impaired Hepatic Function | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07682818) |
| June 25, 2026 | NCT07668388 | A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes | Novo Nordisk A/S | Phase 2 | Recruiting | Diabetes Mellitus, Type 2 | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07668388) |
| June 23, 2026 | NCT07662109 | A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2... | AstraZeneca | Phase 3 | Recruiting | Type 2 Diabetes Mellitus | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07662109) |
| June 23, 2026 | NCT07662044 | A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo... | AstraZeneca | Phase 3 | Recruiting | Type 2 Diabetes Mellitus | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07662044) |
| June 5, 2026 | NCT07630974 | A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01) | Merck Sharp & Dohme LLC | Phase 1/2 | Recruiting | Malignant Neoplasm | 134 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07630974) |
| June 2, 2026 | NCT07621809 | Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease... | Novartis Pharmaceuticals | Phase 3 | Recruiting | Sjögren´s Disease | 570 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07621809) |
| May 29, 2026 | NCT07614776 | A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular... | Amgen | Phase 3 | Recruiting | Neovascular Age-related Macular Degeneration, nAMD | 304 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07614776) |
| May 22, 2026 | NCT07604415 | Active Versus Passive Anal Sphincter Training in Patients With Fecal Incontinence | University Hospital, Martin | Not applicable | Recruiting | Fecal Incontinence | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07604415) |
| May 14, 2026 | NCT07587710 | A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in People With Reduced... | Novo Nordisk A/S | Phase 1 | Recruiting | Overweight, Obesity | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07587710) |
| May 13, 2026 | NCT07584967 | A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure | AnaCardio AB | Phase 2 | Recruiting | Heart Failure With Reduced Ejection Fraction (HFrEF) | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07584967) |
| May 11, 2026 | NCT07577856 | A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis | Janssen Research & Development, LLC | Phase 3 | Recruiting | Colitis, Ulcerative | 644 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07577856) |
| May 11, 2026 | NCT07577843 | A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease | Janssen Research & Development, LLC | Phase 3 | Recruiting | Crohn Disease | 460 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07577843) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Cliniq s.r.o. | Bratislava | 11 |
| Fakultna nemocnica s poliklinikou Nove Zamky | Nové Zámky | 8 |
| Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica | Banská Bystrica | 6 |
| National Cancer Institute | Bratislava | 4 |
| F D Roosevelt University General Hospital Of Banska Bystrica | Banská Bystrica | 3 |
| Nemocnica s poliklinikou Stefana Kukuru Michalovce, a.s. | Michalovce | 3 |
| Premedix Clinic | Bratislava | 2 |
| Nemocnica s poliklinikou Stefana Kukuru Michalovce a.s. | Michalovce | 2 |
| Detska fakultna nemocnica s poliklinikou Banska Bystrica | Banská Bystrica | 2 |
| University Hospital and Comenius University in Bratislava, Derer´s Hospital | Bratislava | 2 |
| MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o. | Banská Bystrica | 2 |
| University Children's Hospital | Bratislava | 2 |
| Summit Clinical Research s.r.o. | Bratislava | 2 |
| Neurologicka ambulancia MUDr.Dupejova s.r.o. | Banská Bystrica | 2 |
| Vychodoslovensky Onkologicky Ustav a.s. | Košice | 2 |
| Vychodoslovensky Onkologicky ustav a.s. | Košice | 2 |
| HUMAN-CARE, s.r.o. | Košice | 2 |
| University Hospital Trnava | Trnava | 2 |
| University hospital Martin | Martin | 2 |
| Summit Clinical Research s.r.o | Bratislava | 2 |
| Ambulancia diabetológie a porúch látkovej premeny a výživy - DIABEDA | Bratislava | 1 |
| Nemocnica s poliklinikou Dunajska Streda, a.s. | Dunajská Streda | 1 |
| Nemocnica s poliklinikou Sv. Lukasa Galanta, a. s. | Galanta | 1 |
| Cardio D&R | Košice | 1 |
| Nemocnica s poliklinikou Spišská Nová Ves | Spišská Nová Ves | 1 |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 7 |
| Phase 1/2 | 4 |
| Phase 2 | 33 |
| Phase 2/3 | 7 |
| Phase 3 | 109 |
| Phase 4 | 1 |
| Not applicable | 25 |
| Observational | 26 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Crohn Disease | 13 |
| Diabetes Mellitus, Type 2 | 11 |
| Colitis, Ulcerative | 11 |
| Obesity | 9 |
| Heart Failure | 8 |
| Cardiovascular Diseases | 6 |
| Overweight | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Neoplasms | 6 |
| Alzheimer Disease | 5 |
| Atrial Fibrillation | 5 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Depressive Disorder, Major | 4 |
| Prostatic Neoplasms | 4 |
| Infections | 4 |
| Renal Insufficiency, Chronic | 4 |
| Coronary Artery Disease | 4 |
| Pulmonary Disease, Chronic Obstructive | 4 |
| Hypertension | 3 |
| Asthma | 3 |
| Depression | 3 |
| Atherosclerosis | 3 |
| Inflammatory Bowel Diseases | 3 |
| Cognitive Dysfunction | 3 |
| Lupus Erythematosus, Systemic | 3 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 15 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 13 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 11 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 9 |
| Comenius University | 9 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 8 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 7 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 7 |
| University Hospital, Martin | 7 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 6 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 5 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 4 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 4 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 3 |
| [Karuna Therapeutics, Inc., a Bristol Myers Squibb company](https://specstream.ai/data/clinical-trials/company/karuna-therapeutics-inc-a-bristol-myers-squibb-company) | 3 |
| [Neurocrine Biosciences](https://specstream.ai/data/clinical-trials/company/neurocrine-biosciences) | 3 |
| [Intra-Cellular Therapies, Inc.](https://specstream.ai/data/clinical-trials/company/intra-cellular-therapies-inc) | 3 |
| [Limacorporate S.p.a](https://specstream.ai/data/clinical-trials/company/limacorporate-s-p-a) | 3 |
| [Genzyme, a Sanofi Company](https://specstream.ai/data/clinical-trials/company/genzyme-a-sanofi-company) | 3 |
| Slovak Academy of Sciences | 2 |
| Gustave Roussy, Cancer Campus, Grand Paris | 2 |
| National Cancer Institute, Slovakia | 2 |
| [Alnylam Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/alnylam-pharmaceuticals) | 2 |
| [argenx](https://specstream.ai/data/clinical-trials/company/argenx) | 2 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Asian restaurants in the United States](https://specstream.ai/data/businesses/asian-restaurants/united-states)
- [Plumbers in the United States](https://specstream.ai/data/businesses/plumbers/united-states)
- [Food and beverage distributors in the United States](https://specstream.ai/data/businesses/food-and-beverage-distributors/united-states)
- [B2B background check companies in the United States](https://specstream.ai/data/businesses/b2b-background-check-companies/united-states)
- [Printing equipment suppliers in the United States](https://specstream.ai/data/businesses/printing-equipment-suppliers/united-states)
- [Gastroenterology practices in the United States](https://specstream.ai/data/businesses/gastroenterology-practices/united-states)
